Bridging Global Disparities in Breast Cancer Care: External Validation Study of the MD Anderson “Nomogram To Predict Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy” and Its Financial Implications of Axillary De-escalation in a Resource Limited Setting
Axillary surgery in breast cancer has evolved from radical dissections to selective de-escalations. Identifying patients who may safely omit sentinel lymph node biopsy (SLNB) can further reduce the surgical burden, post operative complications and financial toxicity associated with breast cancer sur...
Saved in:
| Main Authors: | Vishal Farid Raza FCPS, Ayesha Ehsan FCPS, Amina Iqbal Khan FACS |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Inquiry: The Journal of Health Care Organization, Provision, and Financing |
| Online Access: | https://doi.org/10.1177/00469580251366150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection
by: Eunju Shin, et al.
Published: (2025-05-01) -
Intraoperative predictive model for the detection of metastasis in non-sentinel axillary lymph nodes
by: José Antonio García-Mejido, et al.
Published: (2022-04-01) -
Assessment of the Effect of Treatment with Neoadjuvant Chemotherapy on Breast Cancer Axillary Lymph Node
by: Savelina Popovska, et al.
Published: (2013-12-01) -
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
by: Madeline B. Torres, et al.
Published: (2025-04-01) -
De-escalation of axillary surgery in early breast cancer: translating ACOSOG Z0011 study into clinical practice for breast-conserving surgery patients with positive sentinel lymph node biopsy
by: Mehmet Furkan Sağdıç, et al.
Published: (2025-04-01)